No black box warning on record for Andexxa

As of the latest FDA labeling reviewed, Andexxa (ANDEXANET ALFA) does not carry a black box warning. Standard warnings and precautions still apply — see the full Andexxa medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Arterial and venous thromboembolic events, ischemic events, and cardiac events, including sudden death, have occurred during treatment with ANDEXXA. Resume anticoagulant therapy as soon as medically appropriate following treatment with ANDEXXA . ( 5.1 ) • Unresponsiveness to unfractionated heparin has been reported following ANDEXXA administration. ( 5.2 ) • Re-elevati

No black box warning on record for Andexxa

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Arterial and venous thromboembolic events, ischemic events, and cardiac events, including sudden death, have occurred during treatment with ANDEXXA. Resume anticoagulant therapy as soon as medically appropriate following treatment with ANDEXXA . ( 5.1 ) • Unresponsiveness to unfractionated heparin has been reported following ANDEXXA administration. ( 5.2 ) • Re-elevati

Andexxa Black Box Warning

No black box warning on record for Andexxa

Other warnings & precautions

Andexxa Black Box Warning

No black box warning on record for Andexxa

Other warnings & precautions